Renal Impairment Study With ASP1941

• Status: Completed
• Trial end date: 2010-06-26

Summary

A study to investigate if the pharmacokinetics of ASP1941 is different in Type 2 Diabetes Mellitus (T2DM) patients with different grades of renal failure compared with T2DM patients with normal renal function and healthy volunteers.

• Phase: Phase 1

Details

• Lead Sponsor: Astellas Pharma Inc
• Treatments: Ipragliflozin